ArticleVaccine2010

Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses.

Ana Lucia Dominguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.